Consequently, GeneGo MetaCore’s annotations of biological processes (Supplementary Table S2) revealed that DBNDD1 was significantly associated with a number of metabolic pathways, including the highest ranking of “regulation of GSK3-beta in bipolar disorder” (Figure 8), “ATP/ITP metabolism” (Figure S4A), and “GTP-XTP metabolism” (Figure S4B). Here, DBNDD1 is linked to bipolar disorder.